文献速递白血病

全基因组测序在成人B-其他型急性淋巴细胞白血病中的诊断价值

Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
PubMed 文献 · Blood Adv · 2023-01-01

研究对英国UKALL14试验中652例B细胞前体急性淋巴细胞白血病(BCP-ALL)患者进行筛查,对52例B-其他型患者行肿瘤-正常配对样本全基因组测序(WGS),并与临床及研究细胞遗传学比较。WGS在51/52例中检出癌症相关事件,在5例中检出标准诊疗遗传学漏诊的亚型定义性遗传改变;47例真性B-其他型中41例(87%)检出复发性驱动事件。

要点

  • WGS在51/52例B-其他型ALL中检出癌症相关事件。
  • 5例检出标准诊疗遗传学漏诊的亚型定义性遗传改变。
  • 47例真性B-其他型中41例(87%)检出复发性驱动事件。

核心结论

  • WGS可检出标准诊疗检测漏诊的临床相关遗传异常,并几乎在所有B-其他型ALL病例中识别白血病驱动事件。

研究设计与样本

  • 研究筛查了入组UKALL14的652例BCP-ALL病例,对52例B-其他型患者行肿瘤-正常配对样本全基因组测序,并与临床及研究细胞遗传学数据比较。
  • 对其中31例整合了RNA测序(RNA-seq)分析,包括融合基因检测和基于基因表达的分类。

主要发现

  • WGS在52例B-其他型患者中的51例检出癌症相关事件。
  • 5例检出标准诊疗遗传学先前漏诊的已确立亚型定义性遗传改变。
  • 47例真性B-其他型ALL中,41例(87%)检出复发性驱动事件。
  • 细胞遗传学定义的复杂核型呈现异质性,包括与良好结局(DUX4-r)或不良结局(MEF2D-r和IGK::BCL2)相关的不同遗传改变。
  • 与RNA-seq相比,WGS足以检测和解析复发性遗传亚型,RNA-seq可提供正交验证。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Genomic profiling during the diagnosis of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in adults is used to guide disease classification, risk stratification, and treatment decisions. Patients for whom diagnostic screening fails to identify disease-defining or risk-stratifying lesions are classified as having B-other ALL. We screened a cohort of 652 BCP-ALL cases enrolled in UKALL14 to identify and perform whole genome sequencing (WGS) of paired tumor-normal samples. For 52 patients with B-other, we compared the WGS findings with data from clinical and research cytogenetics. WGS identified a cancer-associated event in 51 of 52 patients, including an established subtype defining genetic alterations that were previously missed with standard-of-care (SoC) genetics in 5 of them. Of the 47 true B-other ALL, we identified a recurrent driver in 87% (41). A complex karyotype via cytogenetics emerges as a heterogeneous group, including distinct genetic alterations associated with either favorable (DUX4-r) or poor outcomes (MEF2D-r and IGK::BCL2). For a subset of 31 cases, we integrated the findings from RNA sequencing (RNA-seq) analysis to include fusion gene detection and classification based on gene expression. Compared with RNA-seq, WGS was sufficient to detect and resolve recurrent genetic subtypes; however, RNA-seq can provide orthogonal validation of findings. In conclusion, we demonstrated that WGS can identify clinically relevant genetic abnormalities missed with SoC testing as well as identify leukemia driver events in virtually all cases of B-other ALL.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Leongamornlert D, Gutiérrez-Abril J, Lee S, et al. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia. Blood Adv. 2023. PMID: 36867579. doi:10.1182/bloodadvances.2022008992

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。